- Home
- / T2 Biosystems
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
T2 Biosystems financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$1
2024-10-29
Market Capitalization
$16.9 M
2024-10-29
Revenue
$7.2 M
FY, 2023
CreditSafe Score
?
Score changed on Jun 06, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 119.0K | 2.8M | 4.1M | 4.7M | 10.5M | 8.3M | 18.1M | 28.1M | 22.3M | 7.2M |
| Revenue growth, % | 2263.9% | 45.0% | ||||||||
| Cost of goods sold | 1.7M | 6.9M | 12.0M | |||||||
| Gross profit | 1.1M | (2.8M) | (7.4M) | |||||||
| Gross profit margin, % | 38.1% | -68.4% | -157.8% | |||||||
| General and administrative expense | 11.0M | 19.1M | 24.1M | 22.8M | 25.7M | 27.3M | 21.3M | 28.5M | 30.6M | 24.8M |
| Operating expense total | 30.8M | 44.5M | 48.1M | 46.5M | 40.2M | 43.6M | 38.2M | 56.4M | ||
| EBIT | (30.7M) | (43.4M) | (50.9M) | (53.9M) | (45.1M) | (52.1M) | (41.4M) | (43.0M) | (55.2M) | (49.7M) |
| EBIT margin, % | -25782.4% | -1542.2% | -1247.0% | -1154.1% | -429.4% | -624.6% | -228.1% | -247.5% | ||
| Interest income | 14.0K | 112.0K | 8.0K | |||||||
| Interest expense | 721.0K | 2.0M | 4.1M | 8.9M | 6.7M | 7.3M | 3.9M | |||
| Net Income | (31.4M) | (45.3M) | (54.8M) | (62.4M) | (51.2M) | (59.0M) | (46.8M) | (49.2M) | (62.0M) | (50.1M) |
| EPS | (12.2) | (19.0) |